Ocular Therapeutix Announces Completion of Debt Refinancing

Ocular Therapeutix, a biopharmaceutical company focused on the formulation, development, and commercialization of innova...

January 1, 2019 | Tuesday | News
Innovus Pharma announces $3.17 million private placement

Innovus Pharmaceuticals, an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effectiv...

January 1, 2019 | Tuesday | News
Nuvo Pharma completes acquisition of Aralez Pharma

Nuvo Pharmaceuticals Inc. a globally focused, Canadian healthcare company with a portfolio of commercial products today ...

January 1, 2019 | Tuesday | News
Apellis Pharmaceuticals’ APL-2 receives orphan drug designation from the FDA

Apellis Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on the development of novel therap...

January 1, 2019 | Tuesday | News
Spirulina extract may provide new therapeutic to fight hypertension: Research

According to a new research by researchers from the Vascular Physiopathology Laboratory of the IRCCS Neuromed in Pozzill...

January 1, 2019 | Tuesday | News
Sistema and VTB to create a major pharmaceuticals holding

Sistema PJSFC (“Sistema”), a publicly traded diversified Russian holding company, announces it has acquired ...

December 31, 2018 | Monday | News
Better mouse model built to enable precision-medicine research for Alzheimer's: NIH

According to a study funded by the National Institute on Aging (NIA), part of the National Institutes of Health, incorpo...

December 31, 2018 | Monday | News
Breast cancer drugs could help treat resistant lung cancers: Research

A class of drugs used to treat certain breast cancers could help to tackle lung cancers that have become resistant to ta...

December 31, 2018 | Monday | News
Opiant Pharma signs licensing pact with Sanofi to treat acute cannabinoid overdose

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing medicines for addictions and drug overdose, ...

December 28, 2018 | Friday | News
Dr. Reddy's lab announces the launch of Sevelamer Carbonate in US

Dr. Reddy’s today announced the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets. It...

December 28, 2018 | Friday | News
DUSA Pharma gets relief prohibiting Biofrontera to use its trade secrets

DUSA Pharmaceuticals, Inc., ("DUSA"), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd announced that DUSA...

December 27, 2018 | Thursday | News
Walgreens Boots Alliance and Verily announce strategic partnership

Walgreens Boots Alliance, Inc. and Verily has announced that they will collaborate on multiple projects under a broad ag...

December 27, 2018 | Thursday | News
Miris Human Milk Analyzer gets FDA nod to market

USFDA permitted marketing of the Miris Human Milk Analyzer, a new diagnostic test to aid healthcare professionals in mea...

December 27, 2018 | Thursday | News
Merck, Pfizer to terminate Phase III JAVELIN Ovarian 100 trial of avelumab

Merck and Pfizer Inc. has announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study...

December 26, 2018 | Wednesday | News
Purdue Foundry Investment Fund provides $750,000 to advance 3 life sciences startups

Purdue Research Foundation’s Foundry Investment Fund has invested a total of $750,000 in three life scie...

December 26, 2018 | Wednesday | News
IBM brings tiny fingernail sensors to monitor health

In new research IBM team details a first-of-a-kind "fingernail sensor" prototype to help monitor human health. The weara...

December 24, 2018 | Monday | News
R&D returns fall to lowest level in nine years: Deloitte, GlobalData

Projected returns on investment in research and development (R&D) for the top 12 biopharmaceutical companies have fa...

December 24, 2018 | Monday | Analysis
Helsinn gives exclusive rights to Menarini for Pracinostat

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biophar...

December 24, 2018 | Monday | News